IDEXX LABORATORIES INC /DE Deferred Income Tax Assets, Net
IDEXX LABORATORIES INC /DE (IDXX) had Deferred Income Tax Assets, Net of $22.67 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-04
- 2026-06-30: Deferred Income Tax Assets, Net $22.67M.
- 2026-03-31: Deferred Income Tax Assets, Net $23.27M.
- 2025-12-31: Deferred Income Tax Assets, Net $27.87M.
- 2025-09-30: Deferred Income Tax Assets, Net $31.50M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $22.67M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $23.27M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $27.87M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $31.50M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $125.02M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $123.08M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $125.63M 10-K · filed 2026-02-20 |
| 2024-09-30 | $134.68M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $126.06M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $106.52M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $107.36M 10-K · filed 2025-02-21 |
| 2023-09-30 | $68.97M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $65.34M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $57.14M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $55.22M 10-K · filed 2024-02-22 |
| 2022-09-30 | $51.94M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $40.55M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $23.09M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $24.78M 10-K · filed 2023-02-16 |
| 2021-09-30 | $24.86M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $26.77M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $28.34M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $31.55M 10-K · filed 2022-02-16 |
| 2020-09-30 | $8.20M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $7.58M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $7.17M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $8.10M 10-K · filed 2021-02-12 |
| 2019-09-30 | $8.40M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $8.74M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $8.37M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $8.48M 10-K · filed 2020-02-14 |
| 2018-09-30 | $8.44M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $8.72M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $9.82M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $7.70M 10-K · filed 2019-02-15 |
| 2017-09-30 | $7.91M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $6.70M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $5.87M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $5.71M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |